Colistin A

Colistin A contains a lipopeptide framework rich in cationic residues that mediate membrane binding and charge-dependent interactions. Cyclic elements promote conformational stability. Researchers explore lipid-association dynamics and folding behavior. Applications include antimicrobial-peptide modeling, biophysical studies, and structure-activity analysis.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Colistin A(CAS 7722-44-3)

CAT No: R2715

CAS No:7722-44-3

Synonyms/Alias:Colistin A;7722-44-3;UNII-500HI50Z9H;500HI50Z9H;COLISTIN A [MI];BRN 0604503;COLISTIN A [WHO-DD];CHEMBL3781027;DTXSID5049079;DTXCID001030474;(6S)-N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide;Colistin A Sulfate Hydrate (~90%);(S)-N-((S)-4-amino-1-(((2S,3R)-1-(((S)-4-amino-1-oxo-1-(((3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-((R)-1-hydroxyethyl)-12,15-diisobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptaazacyclotricosan-21-yl)amino)butan-2-yl)amino)-3-hydroxy-1-oxobutan-2-yl)amino)-1-oxobutan-2-yl)-6-methyloctanamide;L-Threonine, N2-(6-methyl-1-oxooctyl)-L-2,4-diaminobutanoyl-L-threonyl-L-2,4-diaminobutanoyl-L-2,4-diaminobutanoyl-L-2,4-diaminobutanoyl-D-leucyl-L-leucyl-L-2,4-diaminobutanoyl-L-2,4-diaminobutanoyl-, cyclic (10-4)-peptide;1,4,7,10,13,16,19-Heptaazacyclotricosane;NCGC00161620-01;Colistin A sulfate hydrate;SCHEMBL21476977;HY-P2123;Tox21_113638;BDBM50548038;DA-52020;CAS-7722-44-3;CS-0108900;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C53H100N16O13
M.W/Mr.
1169.5

Colistin A, also known as polymyxin E1, is a cationic lipopeptide antibiotic that belongs to the polymyxin family, widely recognized for its potent activity against Gram-negative bacteria. Characterized by its cyclic peptide structure and fatty acid tail, Colistin A exhibits amphipathic properties that facilitate interactions with bacterial membranes, making it a critical tool in microbiological research and various scientific fields. Its unique mechanism of disrupting bacterial cell membrane integrity underpins its widespread adoption in laboratory studies focused on antimicrobial mechanisms, resistance profiling, and the development of novel antibacterial strategies. Due to its ability to selectively target the outer membrane of Gram-negative organisms, Colistin A serves as an essential compound for researchers seeking to elucidate bacterial physiology and to advance the understanding of microbial pathogenesis.

Antimicrobial resistance research: Colistin A plays a pivotal role in studies investigating the mechanisms underlying bacterial resistance to last-line antibiotics. Researchers utilize it to induce selective pressure in bacterial cultures, enabling the identification and characterization of genetic mutations and adaptive responses that confer resistance. This application is instrumental in mapping resistance pathways, understanding the evolution of multidrug-resistant strains, and informing the development of new therapeutic approaches to combat resistant pathogens. Its use in resistance profiling extends to comparative studies with other polymyxins, providing insights into cross-resistance phenomena and the molecular determinants of susceptibility.

Membrane permeability assays: As a prototypical membrane-active agent, polymyxin E1 is widely employed in assays designed to assess outer membrane permeability in Gram-negative bacteria. By disrupting the lipid bilayer and increasing membrane permeability, it allows researchers to quantify the uptake of fluorescent probes, antibiotics, or other molecular tracers. These assays are crucial for evaluating the efficacy of membrane-targeting agents, screening for synergistic drug combinations, and validating the impact of genetic modifications on membrane integrity. The ability of Colistin A to induce controlled membrane perturbation makes it an indispensable reagent in studies aiming to dissect the structural and functional aspects of bacterial envelopes.

Microbial ecology and selective isolation: In environmental and clinical microbiology, Colistin A is incorporated into selective media to suppress the growth of non-target Gram-negative bacteria, thereby facilitating the isolation and enumeration of specific microbial populations. Its selective action enables researchers to recover organisms of interest from complex samples, such as soil, water, or fecal material, by inhibiting competing flora. This application is particularly valuable in studies of microbial diversity, pathogen surveillance, and the monitoring of antimicrobial resistance in environmental reservoirs. By enabling targeted cultivation, Colistin A supports the advancement of microbial ecology and epidemiology research.

Functional genomics and genetic screening: The use of polymyxin E1 extends to functional genomics, where it is applied in high-throughput genetic screens to identify bacterial genes involved in membrane biosynthesis, stress response, and antibiotic resistance. By exposing mutant libraries or knockout strains to the compound, researchers can pinpoint genetic determinants that modulate susceptibility or tolerance. This approach accelerates the discovery of novel drug targets, elucidates gene function, and enhances the understanding of bacterial adaptation mechanisms. The versatility of Colistin A in genetic screening underscores its value in systems biology and molecular microbiology.

Biofilm research and eradication studies: Colistin A is increasingly utilized in investigations focused on biofilm formation, maintenance, and eradication. Its ability to penetrate and disrupt established biofilms makes it a valuable agent for studying biofilm-associated resistance and for evaluating the efficacy of anti-biofilm strategies. Researchers employ it to examine the impact of membrane disruption on biofilm architecture, cell viability, and the release of extracellular polymeric substances. These studies contribute to the development of innovative approaches to control biofilm-related infections and to improve the performance of antimicrobial coatings and materials.

In summary, Colistin A serves as a cornerstone compound in microbiological and biochemical research, supporting a wide spectrum of applications that span antimicrobial resistance studies, membrane permeability assays, selective microbial isolation, functional genomics, and biofilm research. Its unique mode of action and versatility as a research tool continue to drive scientific discovery and innovation in the fields of microbiology, molecular biology, and biotechnology.

InChI
InChI=1S/C53H100N16O13/c1-9-30(6)12-10-11-13-41(72)60-33(14-20-54)48(77)69-43(32(8)71)53(82)65-36(17-23-57)45(74)64-38-19-25-59-52(81)42(31(7)70)68-49(78)37(18-24-58)62-44(73)34(15-21-55)63-50(79)39(26-28(2)3)67-51(80)40(27-29(4)5)66-46(75)35(16-22-56)61-47(38)76/h28-40,42-43,70-71H,9-27,54-58H2,1-8H3,(H,59,81)(H,60,72)(H,61,76)(H,62,73)(H,63,79)(H,64,74)(H,65,82)(H,66,75)(H,67,80)(H,68,78)(H,69,77)/t30-,31+,32+,33-,34-,35-,36-,37-,38-,39-,40+,42-,43-/m0/s1
InChI Key
XDJYMJULXQKGMM-HHAJOKTESA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServiceCustom Conjugation ServicePeptide Nucleic Acids SynthesisPeptide Analysis ServicesPeptide CDMOEpitope Mapping ServicesPeptide Modification ServicesPeptide Synthesis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers